Join Jeff Margolin of First Trust on CEF Insights for a 2025 midyear review of closed-end fund (CEF) performance and expert ...

The International Monetary Fund raised its outlook for economic growth across emerging market and developing economies this ...

Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's ...

In its world economic outlook, the IMF lifted its U.S. growth estimate for 2025 to 1.9% and the 2026 forecast to 2%. That’s ...

U.S.-listed shares of Novo Nordisk sank in premarket trading Tuesday after the Danish drugmaker cut its full-year outlook and ...

Shipowners grapple with OPEC+ supply increases, tensions in the Middle East, and rising numbers of newbuildings.

Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

U.S. growth was expected to reach 1.9% in 2025, up 0.1 percentage point from April's outlook, edging up to 2% in 2026. A new ...

Analysts William Tng and Tan Jie Hui believe Venture’s shares could find “support” at their FY2025 book value per share ...

PepsiCo shares rose Thursday after the beverage and snack food giant affirmed its outlook and posted better-than-estimated ...

XOM, CVX and SHEL face industry headwinds but stand out with strategic acquisitions and strong upstream asset portfolios.